Vicore Pharma Holding AB (OSTO:VICO BTA) Days Inventory : 0.00 (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Vicore Pharma Holding AB Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Vicore Pharma Holding AB's Average Total Inventories for the three months ended in Mar. 2025 was kr0.00 Mil. Vicore Pharma Holding AB's Cost of Goods Sold for the three months ended in Mar. 2025 was kr0.00 Mil.

The historical rank and industry rank for Vicore Pharma Holding AB's Days Inventory or its related term are showing as below:

OSTO:VICO BTA's Days Inventory is not ranked ^*
in the Biotechnology industry.
Industry Median: 179.595
* Ranked among companies with meaningful Days Inventory only.

Vicore Pharma Holding AB's Days Inventory stayed the same from Mar. 2024 (0.00) to Mar. 2025 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Vicore Pharma Holding AB's Inventory-to-Revenue for the three months ended in Mar. 2025 was 0.00.

Vicore Pharma Holding AB Days Inventory Historical Data

The historical data trend for Vicore Pharma Holding AB's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicore Pharma Holding AB Days Inventory Chart

Vicore Pharma Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Inventory

Get a 7-Day Free Trial

Vicore Pharma Holding AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Vicore Pharma Holding AB's Days Inventory

For the Biotechnology subindustry, Vicore Pharma Holding AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vicore Pharma Holding AB's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vicore Pharma Holding AB's Days Inventory distribution charts can be found below:

* The bar in red indicates where Vicore Pharma Holding AB's Days Inventory falls into.

Save Embed

;

Save Embed

;

Vicore Pharma Holding AB Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Vicore Pharma Holding AB's Days Inventory for the fiscal year that ended in Dec. 2024 is calculated as

	Days Inventory (A: Dec. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2023 )	+	Total Inventories (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Vicore Pharma Holding AB's Days Inventory for the quarter that ended in Mar. 2025 is calculated as:

	Days Inventory (Q: Mar. 2025 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Dec. 2024 )	+	Total Inventories (Q: Mar. 2025 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2025 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Vicore Pharma Holding AB (OSTO:VICO BTA) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Vicore Pharma Holding AB's Inventory Turnover for the three months ended in Mar. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Vicore Pharma Holding AB's Inventory to Revenue for the three months ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0.892
	=	0.00

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Vicore Pharma Holding AB Days Inventory Related Terms

Thank you for viewing the detailed overview of Vicore Pharma Holding AB's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicore Pharma Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicore Pharma Holding AB (OSTO:VICO BTA) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

VICO:Sweden

Address

Kornhamnstorg 53, Stockholm, SWE, 111 27

Website

https://www.vicorepharma.com

Vicore Pharma Holding AB is a clinical-stage pharmaceutical company focused on severe lung diseases. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Its C21 is a small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2b development for IPF. The company also has an investigational medical device in clinical development, namely, Almee, which is a digital therapeutic leveraging cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis.

Vicore Pharma Holding AB Headlines

No Headlines